ELASOMERAN

Investigational

Approval Year

Substance Class	Nucleic Acid
Nucleic Acid Type	mRNA VACCINE
Nucleic Acid Subtype	TRANSGENE
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	EPK39PL4R4
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ELASOMERAN

Official Name

English

MODERNA COVID-19 VACCINE RNA

Common Name

English

M-1273

Code

English

TAK-919

Code

English

MRNA-1273

Code

English

Showing 1 to 5 of 13 entries

Previous1 2 3Next

Show entries

Code System

Code

Type

Description

CAS

2430046-03-8

PRIMARY

DRUG BANK

DB15654

PRIMARY

SMS_ID

300000015561

PRIMARY

DAILYMED

EPK39PL4R4

PRIMARY

INN

12065

PRIMARY

Showing 1 to 5 of 8 entries

Previous1 2Next

Subunit 0

Show entries

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_4100	4100 / 4100

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Linkage	Site Range	Site Count
Phosphate	1_2-1_4100	4099 / 4099

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					BP87QBQ8LZ

TOZINAMERAN EXPRESSED SARS COV2 SPIKE-PROTEIN VACCINE ANTIGEN

EXPRESSED PROTEIN->VECTOR

Amount:


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Related Record

Type

Details


					EPK39PL4R4

ELASOMERAN

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Structural Modifications

Show entries

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOTIDE SUBSTITUTION	[1_1]	5'-TERMINUS			5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE	T0HQY09X7B

Showing 1 to 1 of 1 entries

Previous1Next